已收盘 08-01 16:00:00 美东时间
+0.320
+0.37%
Morgan Stanley analyst Patrick Wood maintains Alcon (NYSE:ALC) with a Equal-Weight and lowers the price target from $90 to $84.
07-15 21:04
LumiThera's photobiomodulation (PBM) device is the first and only technology that has demonstrated meaningful visual improvement with two years of treatments* in early and intermediate dry AMD patients1,2Nearly 200
07-07 20:15
2025年1-4月,新能源乘用车L2级及以上的辅助驾驶功能装车率达到77.8%,16万以下市场智驾装车率进一步增长。
06-23 17:05
转自:中国民航网 《中国民航报》、中国民航网记者许晓泓 通讯员代兵报道:6月16日—6月20日,辽宁方大集团副总裁、海航航空集团董事长丁拥政受邀参加第55届巴黎...
06-23 11:05
FDA approves Alcon's Tryptyr for dry eye disease, backed by Phase 3 trials showing strong efficacy in increasing natural tear production.
05-30 01:28
Needham analyst David Saxon reiterates Alcon (NYSE:ALC) with a Buy and maintains $110 price target.
05-14 19:28
With U.S. stock futures trading slightly higher this morning on Wednesday, some...
05-14 19:03
Alcon (NYSE:ALC) lowers FY2025 Adj EPS guidance from $3.15-$3.25 to $3.05-$3.15 vs $3.20 analyst estimate. Raises FY2025 sales outlook from $10.20 billion-$10.40 billion to $10.40 billion-$10.50 billion vs $10.42 billion
05-14 04:32
Alcon (NYSE:ALC) reported quarterly earnings of $0.73 per share which missed the analyst consensus estimate of $0.75 by 2.67 percent. This is a 6.41 percent decrease over earnings of $0.78 per share from the same period
05-14 04:31